Infección perinatal por estreptococo del grupo B

1. Raabe VN, Shane AL, Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019;7(2): 10.1128/microbiolspec.GPP3-0007-2018

2. Prevention of group B Streptococcal early-onset disease in newborns: ACOG committee opinion, number 797. Obstet Gynecol. 2020;135(2):e51–e72

3. Puopolo KM, Lynfield R, Cummings JJ; Committee on Fetus and Newborn; Committee on Infectious Diseases. Management of infants at risk for group B Streptococcal disease. Pediatrics.

2019;144(2):e20191881

4. Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138(6):e20162013

5. Stoll BJ, Puopolo KM, Hansen NI, et al; and the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies. JAMA Pediatr. 2020;174(7):e200593

6. Centers for Disease Control and Prevention. Prevention of perinatal group B Streptococcal disease: a public health perspective. MMWR Recomm Rep. 1996;45(RR-7):1–24

7. Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early onset and late-onset group B Streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 2019;173(3):224–233

8. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B Streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1–22

9. Schrag SJ, Zell ER, Lynfield R, et al; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B Streptococcal disease in neonates. N Engl J Med. 2002; 347(4):233–239

10. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B Streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010; 59(RR-10):1–36

11. Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B

Streptococcal vaccine. Vaccine. 2013; 31(suppl 4):D20–D26

12. Phares CR, Lynfield R, Farley MM, et al; Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B Streptococcal disease in the United States, 1999-2005. JAMA. 2008; 299 (17): 2056–2065

13. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B Streptococcal infection. N Engl J Med. 1976;294(14):753–756

14. Baker CJ, Carey VJ, Rench MA, et al. Maternal antibody at delivery protects neonates from early onset group B Streptococcal disease. J Infect Dis. 2014;209(5):781–788

15. Berardi A, Rossi C, Creti R, et al. Group B Streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. J Pediatr. 2013;163(4):1099–104.e1

16. Filleron A, Lombard F, Jacquot A, et al. Group B streptococci in milk and late neonatal infections: an analysis of cases in the literature. Arch Dis Child Fetal Neonatal Ed. 2014;99(1):F41–F47

17. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30(11):937–941

18. Centers for Disease Control and Prevention. Active bacterial core surveillance report, Emerging Infections Program Network. Available at: https://www.cdc.gov/abcs/reports-findings/

survreports/gbs18.html. Accessed December 9, 2020

19. Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B Streptococcal. N Engl J Med. 2009;360(25):2626–2636

20. Yow MD, Mason EO, Leeds LJ, Thompson PK, Clark DJ, Gardner SE. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA. 1979;241(12):1245–1247

21. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B Streptococcal early-onset disease: III, interruption of mother-to-infant transmission. J Infect Dis. 1983;148(5):810–816

22. Russell NJ, Seale AC, O’Driscoll M, et al; GBS Maternal Colonization Investigator Group. Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S100–S111

23. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B Streptococcal disease in the era of maternal screening. Pediatrics. 2005;115(5):1240–1246

24. Fay K, Almendares O, Robinson-Dunn B, Schrag S. Antenatal and intrapartum nucleic acid amplification test use for group B Streptococcus screening-United States, 2016. Diagn Microbiol Infect Dis. 2019;94(2):157–159